Great news first of 5 people treated, CUV should update the market over the coming months on DNA repair and other trials currently on the go.
So much potential here if management stop selling
Ann: Media release - First stroke patient with afamelanotide, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$11.96 |
Change
-0.295(2.41%) |
Mkt cap ! $606.4M | |||
| Open | High | Low | Value | Volume |
| $12.25 | $12.28 | $11.44 | $1.564M | 131.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8 | $11.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.97 | 300 | 8 |
View Market Depth
| Last trade - 15.31pm 23/07/2025 (20 minute delay) ? |
| CUV (ASX) Chart |